Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Receivables: 2011-2019

Historic Receivables for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $2.3 million.

  • EyePoint Pharmaceuticals' Receivables rose 792.49% to $2.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $3.5 million, marking a year-over-year increase of 223.54%. This contributed to the annual value of $353,000 for FY2018, which is 40.64% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Receivables stood at $2.3 million for Q1 2019, which was up 260.13% from $627,000 recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Receivables high stood at $2.3 million for Q1 2019, and its period low was $251,000 during Q2 2017.
  • Its 3-year average for Receivables is $541,111, with a median of $288,000 in 2017.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Receivables tumbled by 97.77% in 2015 and then skyrocketed by 792.49% in 2019.
  • EyePoint Pharmaceuticals' Receivables (Quarterly) stood at $573,000 in 2015, then decreased by 20.24% to $457,000 in 2016, then plummeted by 36.98% to $288,000 in 2017, then surged by 117.71% to $627,000 in 2018, then skyrocketed by 792.49% to $2.3 million in 2019.
  • Its Receivables stands at $2.3 million for Q1 2019, versus $627,000 for Q4 2018 and $253,000 for Q3 2018.